Phae II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy

Cancer Treat Rep. 1978 Jan;62(1):173-5.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkylating Agents / therapeutic use
  • Altretamine / adverse effects
  • Altretamine / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Drug Evaluation
  • Drug Resistance
  • Female
  • Humans
  • Middle Aged
  • Nausea / chemically induced
  • Neoplasm Metastasis / drug therapy
  • Nervous System / drug effects
  • Triazines / therapeutic use*
  • Vomiting / chemically induced

Substances

  • Alkylating Agents
  • Triazines
  • Altretamine